James A. Schoeneck - 30 Jun 2025 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Director
Signature
/s/ Michael Hom, Attorney-in-Fact
Issuer symbol
FGEN
Transactions as of
30 Jun 2025
Net transactions value
+$119,485
Form type
4
Filing time
02 Jul 2025, 16:33:27 UTC
Previous filing
06 Jun 2025
Next filing
15 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schoeneck James A Director C/O FIBROGEN, INC., 350 BAY STREET, SUITE 100, #6009, SAN FRANCISCO /s/ Michael Hom, Attorney-in-Fact 02 Jul 2025 0001420987

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Purchase $119,485 +23,567 +146% $5.07* 39,666 30 Jun 2025 By Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $4.935 to $5.25. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
F2 Reflects a 1-for-25 reverse stock split effective on June 16, 2025.